News

PDI had been struggling with a customer dataset of millions of physicians, nurse practitioners, pharmacists and other healthcare professionals (HCPs)

Zephyr Illuminate pools disparate data for predictive analytics for commercial operations

'European companies will not be able to follow the exact path to operational compliance as their US counterparts,' says IMS Health survey

New center near Almac's Northern Ireland HQ expedites shipments worldwide

A Common Universal Patient de-IDentifier could greatly enhance the value of industry data assets

Fees paid to FDA by small generic manufacturers are financially 'unfair'

Are hubs a help or hindrance in getting patients on therapy?

A contractual arrangement that could save time and money for brand owners

While temperature-controlled components advance, service providers are identifying innovative refinements to basic shipping services

Trial start-up steps, and overall content management, are Veeva Vault cloud offerings

Plays catchup with CVS Health

Acquisition adds more expertise in epidemiology and patient outcomes analysis

Senate committee targets Valeant and Turing Pharma; House Democrats lean on Republican committee leadership to act

Even with legislative incentives, pharma manufacturers struggle to cost-justify pediatric innovation

European experience to date indicates a changing perspective on biosimilar pricing

The right studies at the right time in the right way to meet real-world evidence needs

Packaging-line engineers are going into overdrive as industry gets ready for the 2017 unit-serialization mandate

Consolidation in the contract sales organization (CSO) space

IC Optix wins a US patent for film overlay of labels

HHS will hold a webcasted meeting of stakeholders to address pricing issues

Likely Pfizer-Allergan friendly merger pairs with Walgreens-Rite Aid as concerns over concentration mount

Valeant severs ties and says the pharmacy is closing shop

FDA fiddles with legislated deadline schedule

Facility manages clinical trial supply, storage, packaging and distribution

Valeant-Philidor dispute causes a 'mischaracterization' of specialty pharmacy